You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

secondary resistance

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GIST Trial in Xi'an (Imatinib)

Recruiting
  • GIST
  • Xi'an, Shaanxi, China
    Xijing Hospital of Air Force Military Medical University
Jun 8, 2023

Lumoptik BRIGHTPOINT Reflectometer Device for Lumbar Epidural

Not yet recruiting
  • Lumbar Spine Surgery
  • Group 1 - Lumoptik BrightPoint Epidural Device
  • (no location specified)
Aug 28, 2023

Effect of Drug, Toxicity, Drug, Secondary Resistance Trial in Beijing (Apatinib Mesylate, ifosfamide and etoposide)

Completed
  • Effect of Drug
  • +2 more
  • Apatinib Mesylate
  • ifosfamide and etoposide
  • Beijing, Beijing, China
    Peking University People's Hospital
Mar 12, 2022

Epidural Placement Trial in Cleveland (BrightPoint)

Not yet recruiting
  • Epidural Placement
  • BrightPoint
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Dec 14, 2022

Sarcopenia Trial in Hail (high intensity exercises, low intensity aerobic exercises)

Not yet recruiting
  • Sarcopenia
  • high intensity exercises
  • low intensity aerobic exercises
  • Hail, Saudi Arabia
    King Khalid Hospital
Dec 11, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Greifswald, Halle (Saale) (Fedratinib Oral Capsule [Inrebic], Nivolumab)

Recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Greifswald, Germany
  • +1 more
Jun 15, 2022

Hepatic Encephalopathy Trial (Rifaximin)

Completed
  • Hepatic Encephalopathy
  • (no location specified)
Feb 1, 2021

Melanoma Trial in Worldwide (Ceralasertib, Durvalumab)

Recruiting
  • Melanoma
  • Los Angeles, California
  • +75 more
Dec 5, 2022

Cancer Trial in Worldwide (Dabrafenib, Trametinib, Panitumumab)

Completed
Has Results
  • Cancer
  • Scottsdale, Arizona
  • +19 more
Sep 30, 2021

Insulin Infusion and Infectious Diabetic Foot Ulcers (IIIFU)

Withdrawn
  • Diabetes Mellitus
  • +3 more
  • Insulin infusion (aspart)
  • Standard care
  • Stockholm, Sweden
    Department of Molecular Medicine and Surgery, Rolf Luft Research
Sep 30, 2020

NSCLC Trial in Amsterdam (Ipilimumab, Cemiplimab, SBRT)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Amsterdam, Noord-Holland, Netherlands
    Antoni van Leeuwenhoek - Netherlands Cancer Institute
Jan 10, 2023

Resistance in ER+ Breast Cancer Patients:Translational Project

Recruiting
  • Breast Cancer
    • Aviano, Pordenone, Italy
    • +1 more
    Nov 8, 2023

    Physical Activity Trial in Fredericton (Resistance Training with Blood flow restriction)

    Recruiting
    • Physical Activity
    • Resistance Training with Blood flow restriction
    • Fredericton, New Brunswick, Canada
      University of New Brunswick - Kinesiology
    Nov 7, 2022

    GIST: Assessment of Tumor Mutations and TKI Plasma Exposure

    Recruiting
    • Gastro-intestinal Stromal Tumor
    • Vena puncture for blood collection
    • Tumor biopsy
    • Amsterdam, Netherlands
    • +4 more
    May 17, 2022

    Hypoxia, Altitude Trial (Inspiratory Muscle Training (IMT), Normal Breathing)

    Not yet recruiting
    • Hypoxia, Altitude
    • Inspiratory Muscle Training (IMT)
    • Normal Breathing
    • (no location specified)
    Nov 5, 2023

    Achilles Tendinopathy Trial (Homebased resistance training, Supervised heavy slow resistance training)

    Recruiting
    • Achilles Tendinopathy
    • Homebased resistance training
    • Supervised heavy slow resistance training
    • Copenhagen, Denmark
      Bispebjerg Hospital
    Dec 12, 2022

    Type 2 Diabetes Trial in Nanjing (AR group: aerobic training before resistance training, RA group: resistance exercise before

    Recruiting
    • Type 2 Diabetes
    • AR group: aerobic training before resistance training
    • RA group: resistance exercise before aerobic exercise
    • Nanjing, Jiangsu, China
      Maigaoqiao Community Health Service Center
    Nov 17, 2023

    Resistance Training, Blood Flow Restriction Therapy, Anterior Cruciate Ligament Reconstruction Trial in Lahore (High intensity

    Recruiting
    • Resistance Training
    • +3 more
    • High intensity Traditional Resistance Traning without Blood Flow Restriction
    • High intensity Traditional Resistance Traning with Blood Flow Restriction
    • Lahore, Punjab, Pakistan
      Ghurki Trust & Teaching Hospital
    Nov 9, 2023

    Young Adults Trial in Islamabad (Resistance Training, General Fitness and Toning)

    Recruiting
    • Young Adults
    • Resistance Training
    • General Fitness and Toning
    • Islamabad, Islamabad Capital Territory, Pakistan
      Riphah International University (RIU)
    Oct 11, 2023

    Novel, Rapid Diagnostic for Gonorrhoea and Mycoplasma

    Recruiting
    • Sexually Transmitted Diseases, Bacterial
    • Antibiotic Resistant Infection
      • Llantrisant, Rhondda Cynon Taf, United Kingdom
      • +1 more
      May 20, 2022

      Carbapenem-Resistant Enterobacteriaceae Infection Trial in Jinan (CAZ/AVI plus Aztreonam, Conventional treatment)

      Recruiting
      • Carbapenem-Resistant Enterobacteriaceae Infection
      • CAZ/AVI plus Aztreonam
      • Conventional treatment
      • Jinan, Shandong, China
        Mingju Hao
      Apr 29, 2023

      Carcinoma, Non-Small Cell Lung, EGFR Gene Mutation Trial in Changsha (Gemcitabine platinum combined with erlotinib)

      Recruiting
      • Carcinoma, Non-Small Cell Lung
      • EGFR Gene Mutation
      • Gemcitabine platinum combined with erlotinib
      • Changsha, Hunan, China
        Hunan Province Tumor Hospital
      Feb 28, 2022

      Cognitive Function Trial (High intensity resistance training, Low intensity resistance training)

      Not yet recruiting
      • Cognitive Function
      • High intensity resistance training
      • Low intensity resistance training
      • (no location specified)
      Oct 27, 2023

      NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Nintedanib)

      Active, not recruiting
      Has Results
      • Carcinoma, Non-Small-Cell Lung
      • +2 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jan 3, 2023

      Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy Trial in United States (Emavusertib, ibrutinib)

      Recruiting
      • Relapsed Hematologic Malignancy
      • Refractory Hematologic Malignancy
      • Phoenix, Arizona
      • +10 more
      Feb 1, 2023